Johnson & Johnson is one of the largest healthcare and consumer product companies in the world, employing 136,500 people. Revenues of between $88-90 billion are expected for 2021. Its three divisions comprise Consumer, Pharmaceutical, and Medical Devices.
Wealth Builder
Sorry, you do not have access to this content.Income Investor
Sorry, you do not have access to this content.We took half profits a couple of years ago. The shares are down 5% over the last year, bringing its forward price/earnings ratio to below 15. The stock remains a Buy. - Gavin Graham
Current Advice
Buy
Consult your broker/advisor
Capital Gain/Loss
147.4%
Interactive Performance Chart
JNJ was first recommended here on October 27, 2010